FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2078169214> ?p ?o ?g. }

• W2078169214 endingPage "115" @default.
• W2078169214 startingPage "111" @default.
• W2078169214 abstract "The recurrence of ischemic cerebrovascular events despite treatment with aspirin (ASA) and/or clopidogrel remains a serious problem. Although there is increasing evidence that clinical failure may at least partially result from the nonresponsiveness of platelets to medication, the adjustment of the therapy according to ex vivo platelet responses is not yet common in clinical practice. Here, we compare two commonly used ex vivo platelet function tests under different treatment conditions. Blood samples from 142 patients with cerebrovascular disease receiving either ASA, clopidogrel, or a combined treatment, and 51 controls were evaluated by the platelet function analyzer (PFA)-100 (collagen/epinephrine cartridge), as well as collagen and ADP-induced aggregometry. The tests all demonstrated the interindividual heterogeneity of platelet aggregation inhibition, but the fractions of nonresponsiveness differed considerably with 58-62% of patients being nonresponsive to ASA by PFA-100 compared with 27-33% by collagen-induced aggregation. The clopidogrel nonresponsiveness was 44% by ADP-induced aggregation. The agreement of the test values between PFA-100 and collagen-induced aggregometry was weak (correlation coefficient r= –0.1 to –0.3). Only about half of the patients were consistently identified as either ASA responsive or nonresponsive by both tests. Under dual therapy conditions, the unspecificity of aggregometric tests prevented reliable measurements of platelet responses. In conclusion, there are currently considerable limitations in platelet aggregation monitoring. Nevertheless, we encourage prospective trials to improve the predictive value of platelet aggregation testing and to prove whether a systematic strategy of “platelet aggregation–adapted treatment” will improve the clinical outcome of patients with cerebrovascular events. The recurrence of ischemic cerebrovascular events despite treatment with aspirin (ASA) and/or clopidogrel remains a serious problem. Although there is increasing evidence that clinical failure may at least partially result from the nonresponsiveness of platelets to medication, the adjustment of the therapy according to ex vivo platelet responses is not yet common in clinical practice. Here, we compare two commonly used ex vivo platelet function tests under different treatment conditions. Blood samples from 142 patients with cerebrovascular disease receiving either ASA, clopidogrel, or a combined treatment, and 51 controls were evaluated by the platelet function analyzer (PFA)-100 (collagen/epinephrine cartridge), as well as collagen and ADP-induced aggregometry. The tests all demonstrated the interindividual heterogeneity of platelet aggregation inhibition, but the fractions of nonresponsiveness differed considerably with 58-62% of patients being nonresponsive to ASA by PFA-100 compared with 27-33% by collagen-induced aggregation. The clopidogrel nonresponsiveness was 44% by ADP-induced aggregation. The agreement of the test values between PFA-100 and collagen-induced aggregometry was weak (correlation coefficient r= –0.1 to –0.3). Only about half of the patients were consistently identified as either ASA responsive or nonresponsive by both tests. Under dual therapy conditions, the unspecificity of aggregometric tests prevented reliable measurements of platelet responses. In conclusion, there are currently considerable limitations in platelet aggregation monitoring. Nevertheless, we encourage prospective trials to improve the predictive value of platelet aggregation testing and to prove whether a systematic strategy of “platelet aggregation–adapted treatment” will improve the clinical outcome of patients with cerebrovascular events." @default.
• W2078169214 created "2016-06-24" @default.
• W2078169214 creator A5036494368 @default.
• W2078169214 creator A5070791712 @default.
• W2078169214 creator A5084472327 @default.
• W2078169214 date "2009-03-01" @default.
• W2078169214 modified "2023-09-27" @default.
• W2078169214 title "Towards a Rationale of Platelet Aggregation Monitoring in Stroke Prophylaxis?" @default.
• W2078169214 cites W13025780 @default.
• W2078169214 cites W1964095591 @default.
• W2078169214 cites W1978432681 @default.
• W2078169214 cites W1989615944 @default.
• W2078169214 cites W1995862697 @default.
• W2078169214 cites W2010222811 @default.
• W2078169214 cites W2012214760 @default.
• W2078169214 cites W2015521606 @default.
• W2078169214 cites W2019399894 @default.
• W2078169214 cites W2024352468 @default.
• W2078169214 cites W2059064084 @default.
• W2078169214 cites W2061975208 @default.
• W2078169214 cites W2072515160 @default.
• W2078169214 cites W2100209149 @default.
• W2078169214 cites W2109693064 @default.
• W2078169214 cites W2143852297 @default.
• W2078169214 cites W2147294426 @default.
• W2078169214 cites W2151231973 @default.
• W2078169214 cites W2169874186 @default.
• W2078169214 cites W4297812089 @default.
• W2078169214 doi "https://doi.org/10.1016/j.jstrokecerebrovasdis.2008.09.010" @default.
• W2078169214 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19251186" @default.
• W2078169214 hasPublicationYear "2009" @default.
• W2078169214 type Work @default.
• W2078169214 sameAs 2078169214 @default.
• W2078169214 citedByCount "19" @default.
• W2078169214 countsByYear W20781692142012 @default.
• W2078169214 countsByYear W20781692142013 @default.
• W2078169214 countsByYear W20781692142015 @default.
• W2078169214 countsByYear W20781692142017 @default.
• W2078169214 countsByYear W20781692142018 @default.
• W2078169214 crossrefType "journal-article" @default.
• W2078169214 hasAuthorship W2078169214A5036494368 @default.
• W2078169214 hasAuthorship W2078169214A5070791712 @default.
• W2078169214 hasAuthorship W2078169214A5084472327 @default.
• W2078169214 hasConcept C126322002 @default.
• W2078169214 hasConcept C127413603 @default.
• W2078169214 hasConcept C150903083 @default.
• W2078169214 hasConcept C164705383 @default.
• W2078169214 hasConcept C207001950 @default.
• W2078169214 hasConcept C26291073 @default.
• W2078169214 hasConcept C2775859304 @default.
• W2078169214 hasConcept C2777628954 @default.
• W2078169214 hasConcept C2777849778 @default.
• W2078169214 hasConcept C2780645631 @default.
• W2078169214 hasConcept C2993802102 @default.
• W2078169214 hasConcept C535046627 @default.
• W2078169214 hasConcept C71924100 @default.
• W2078169214 hasConcept C78519656 @default.
• W2078169214 hasConcept C86803240 @default.
• W2078169214 hasConcept C89560881 @default.
• W2078169214 hasConcept C98274493 @default.
• W2078169214 hasConceptScore W2078169214C126322002 @default.
• W2078169214 hasConceptScore W2078169214C127413603 @default.
• W2078169214 hasConceptScore W2078169214C150903083 @default.
• W2078169214 hasConceptScore W2078169214C164705383 @default.
• W2078169214 hasConceptScore W2078169214C207001950 @default.
• W2078169214 hasConceptScore W2078169214C26291073 @default.
• W2078169214 hasConceptScore W2078169214C2775859304 @default.
• W2078169214 hasConceptScore W2078169214C2777628954 @default.
• W2078169214 hasConceptScore W2078169214C2777849778 @default.
• W2078169214 hasConceptScore W2078169214C2780645631 @default.
• W2078169214 hasConceptScore W2078169214C2993802102 @default.
• W2078169214 hasConceptScore W2078169214C535046627 @default.
• W2078169214 hasConceptScore W2078169214C71924100 @default.
• W2078169214 hasConceptScore W2078169214C78519656 @default.
• W2078169214 hasConceptScore W2078169214C86803240 @default.
• W2078169214 hasConceptScore W2078169214C89560881 @default.
• W2078169214 hasConceptScore W2078169214C98274493 @default.
• W2078169214 hasIssue "2" @default.
• W2078169214 hasLocation W20781692141 @default.
• W2078169214 hasLocation W20781692142 @default.
• W2078169214 hasOpenAccess W2078169214 @default.
• W2078169214 hasPrimaryLocation W20781692141 @default.
• W2078169214 hasRelatedWork W1967434490 @default.
• W2078169214 hasRelatedWork W1981235165 @default.
• W2078169214 hasRelatedWork W1993423973 @default.
• W2078169214 hasRelatedWork W2000826692 @default.
• W2078169214 hasRelatedWork W2014904348 @default.
• W2078169214 hasRelatedWork W2076882930 @default.
• W2078169214 hasRelatedWork W2093561137 @default.
• W2078169214 hasRelatedWork W2107609077 @default.
• W2078169214 hasRelatedWork W2189601282 @default.
• W2078169214 hasRelatedWork W7808146 @default.
• W2078169214 hasVolume "18" @default.
• W2078169214 isParatext "false" @default.
• W2078169214 isRetracted "false" @default.
• W2078169214 magId "2078169214" @default.
• W2078169214 workType "article" @default.